1
|
Roberts EG, Kleptsyn VF, Roberts GD, Mossburg KJ, Feng B, Domian IJ, Emani SM, Wong JY. Development of a bio-MEMS device for electrical and mechanical conditioning and characterization of cell sheets for myocardial repair. Biotechnol Bioeng 2019; 116:3098-3111. [PMID: 31317531 DOI: 10.1002/bit.27123] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2019] [Revised: 05/09/2019] [Accepted: 07/09/2019] [Indexed: 12/26/2022]
Abstract
Here we propose a bio-MEMS device designed to evaluate contractile force and conduction velocity of cell sheets in response to mechanical and electrical stimulation of the cell source as it grows to form a cellular sheet. Moreover, the design allows for the incorporation of patient-specific data and cell sources. An optimized device would allow cell sheets to be cultured, characterized, and conditioned to be compatible with a specific patient's cardiac environment in vitro, before implantation. This design draws upon existing methods in the literature but makes an important advance by combining the mechanical and electrical stimulation into a single system for optimized cell sheet growth. The device has been designed to achieve cellular alignment, electrical stimulation, mechanical stimulation, conduction velocity readout, contraction force readout, and eventually cell sheet release. The platform is a set of comb electrical contacts consisting of three-dimensional walls made of polydimethylsiloxane and coated with electrically conductive metals on the tops of the walls. Not only do the walls serve as a method for stimulating cells that are attached to the top, but their geometry is tailored such that they are flexible enough to be bent by the cells and used to measure force. The platform can be stretched via a linear actuator setup, allowing for simultaneous electrical and mechanical stimulation that can be derived from patient-specific clinical data.
Collapse
Affiliation(s)
- Erin G Roberts
- Division of Materials Science and Engineering, Boston University, Boston, Massachusetts.,Department of Cardiac Surgery, Boston Children's Hospital, Boston, Massachusetts
| | - Vladimir F Kleptsyn
- Department of Electrical and Computer Engineering, Boston University, Boston, Massachusetts
| | - Gregory D Roberts
- Department of Applied Physics and Materials Science, California Institute of Technology, Pasadena, California
| | | | - Bei Feng
- Harvard Medical School, Massachusetts General Hospital, Cardiovascular Research Center, Boston, Massachusetts
| | - Ibrahim J Domian
- Harvard Medical School, Massachusetts General Hospital, Cardiovascular Research Center, Boston, Massachusetts
| | - Sitaram M Emani
- Department of Cardiac Surgery, Boston Children's Hospital, Boston, Massachusetts
| | - Joyce Y Wong
- Division of Materials Science and Engineering, Boston University, Boston, Massachusetts.,Department of Biomedical Engineering, Boston University, Boston, Massachusetts
| |
Collapse
|
2
|
Tang JD, Roloson EB, Amelung CD, Lampe KJ. Rapidly Assembling Pentapeptides for Injectable Delivery (RAPID) Hydrogels as Cytoprotective Cell Carriers. ACS Biomater Sci Eng 2019; 5:2117-2121. [DOI: 10.1021/acsbiomaterials.9b00389] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Affiliation(s)
- James D. Tang
- Department of Chemical Engineering, University of Virginia, 102 Engineers’ Way, Charlottesville, Virginia 22904, United States
| | - Emily B. Roloson
- Department of Biomedical Engineering, University of Virginia, 415 Lane Road, Charlottesville, Virginia 22904, United States
| | - Connor D. Amelung
- Department of Biomedical Engineering, University of Virginia, 415 Lane Road, Charlottesville, Virginia 22904, United States
| | - Kyle J. Lampe
- Department of Chemical Engineering, University of Virginia, 102 Engineers’ Way, Charlottesville, Virginia 22904, United States
| |
Collapse
|
3
|
Kong YP, Rioja AY, Xue X, Sun Y, Fu J, Putnam AJ. A systems mechanobiology model to predict cardiac reprogramming outcomes on different biomaterials. Biomaterials 2018; 181:280-292. [PMID: 30096562 DOI: 10.1016/j.biomaterials.2018.07.036] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2018] [Revised: 06/27/2018] [Accepted: 07/24/2018] [Indexed: 12/13/2022]
Abstract
During normal development, the extracellular matrix (ECM) regulates cell fate mechanically and biochemically. However, the ECM's influence on lineage reprogramming, a process by which a cell's developmental cycle is reversed to attain a progenitor-like cell state followed by subsequent differentiation into a desired cell phenotype, is unknown. Using a material mimetic of the ECM, here we show that ligand identity, ligand density, and substrate modulus modulate indirect cardiac reprogramming efficiency, but were not individually correlated with phenotypic outcomes in a predictive manner. Alternatively, we developed a data-driven model using partial least squares regression to relate short-term cell states, defined by quantitative mechanosensitive responses to different material environments, with long-term changes in phenotype. This model was validated by accurately predicting the reprogramming outcomes on a different material platform. Collectively, these findings suggest a means to rapidly screen candidate biomaterials that support reprogramming with high efficiency, without subjecting cells to the entire reprogramming process.
Collapse
Affiliation(s)
- Yen P Kong
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA
| | - Ana Y Rioja
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA
| | - Xufeng Xue
- Department of Mechanical Engineering, University of Michigan, Ann Arbor, Michigan, USA
| | - Yubing Sun
- Department of Mechanical and Industrial Engineering, University of Massachusetts, Amherst, MA, USA
| | - Jianping Fu
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA; Department of Mechanical Engineering, University of Michigan, Ann Arbor, Michigan, USA; Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan, USA
| | - Andrew J Putnam
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA; Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, USA.
| |
Collapse
|
4
|
Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications. Cells 2018; 7:cells7060048. [PMID: 29799480 PMCID: PMC6025241 DOI: 10.3390/cells7060048] [Citation(s) in RCA: 38] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Revised: 05/16/2018] [Accepted: 05/22/2018] [Indexed: 12/11/2022] Open
Abstract
Human-induced pluripotent stem cells (hiPSCs) are reprogrammed cells that have hallmarks similar to embryonic stem cells including the capacity of self-renewal and differentiation into cardiac myocytes. The improvements in reprogramming and differentiating methods achieved in the past 10 years widened the use of hiPSCs, especially in cardiac research. hiPSC-derived cardiac myocytes (CMs) recapitulate phenotypic differences caused by genetic variations, making them attractive human disease models and useful tools for drug discovery and toxicology testing. In addition, hiPSCs can be used as sources of cells for cardiac regeneration in animal models. Here, we review the advances in the genetic and epigenetic control of cardiomyogenesis that underlies the significant improvement of the induced reprogramming of somatic cells to CMs; the methods used to improve scalability of throughput assays for functional screening and drug testing in vitro; the phenotypic characteristics of hiPSCs-derived CMs and their ability to rescue injured CMs through paracrine effects; we also cover the novel approaches in tissue engineering for hiPSC-derived cardiac tissue generation, and finally, their immunological features and the potential use in biomedical applications.
Collapse
|
5
|
Tang JD, Lampe KJ. From de novo peptides to native proteins: advancements in biomaterial scaffolds for acute ischemic stroke repair. Biomed Mater 2018; 13:034103. [DOI: 10.1088/1748-605x/aaa4c3] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
6
|
Slamecka J, McClellan S, Wilk A, Laurini J, Manci E, Hoerstrup SP, Weber B, Owen L. Induced pluripotent stem cells derived from human amnion in chemically defined conditions. Cell Cycle 2018; 17:330-347. [PMID: 29143560 DOI: 10.1080/15384101.2017.1403690] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Fetal stem cells are a unique type of adult stem cells that have been suggested to be broadly multipotent with some features of pluripotency. Their clinical potential has been documented but their upgrade to full pluripotency could open up a wide range of cell-based therapies particularly suited for pediatric tissue engineering, longitudinal studies or disease modeling. Here we describe episomal reprogramming of mesenchymal stem cells from the human amnion to pluripotency (AM-iPSC) in chemically defined conditions. The AM-iPSC expressed markers of embryonic stem cells, readily formed teratomas with tissues of all three germ layers present and had a normal karyotype after around 40 passages in culture. We employed novel computational methods to determine the degree of pluripotency from microarray and RNA sequencing data in these novel lines alongside an iPSC and ESC control and found that all lines were deemed pluripotent, however, with variable scores. Differential expression analysis then identified several groups of genes that potentially regulate this variability in lines within the boundaries of pluripotency, including metallothionein proteins. By further studying this variability, characteristics relevant to cell-based therapies, like differentiation propensity, could be uncovered and predicted in the pluripotent stage.
Collapse
Affiliation(s)
| | | | - Anna Wilk
- a Mitchell Cancer Institute, University of South Alabama , USA
| | - Javier Laurini
- c College of Medicine, University of South Alabama , Mobile , AL , USA
| | - Elizabeth Manci
- d College of Medicine, University of South Alabama , Mobile , AL , USA
| | - Simon P Hoerstrup
- b Institute for Regenerative Medicine, University of Zurich , Switzerland.,f Center for Applied Biotechnology and Molecular Medicine (CABMM) , University of Zurich - Irchel Campus , Zurich , Switzerland
| | - Benedikt Weber
- b Institute for Regenerative Medicine, University of Zurich , Switzerland.,e Department of Dermatology , University Hospital Zurich , Switzerland.,f Center for Applied Biotechnology and Molecular Medicine (CABMM) , University of Zurich - Irchel Campus , Zurich , Switzerland
| | - Laurie Owen
- g University of California San Diego , La Jolla , CA , USA
| |
Collapse
|
7
|
Bakhshandeh B, Zarrintaj P, Oftadeh MO, Keramati F, Fouladiha H, Sohrabi-Jahromi S, Ziraksaz Z. Tissue engineering; strategies, tissues, and biomaterials. Biotechnol Genet Eng Rev 2018; 33:144-172. [PMID: 29385962 DOI: 10.1080/02648725.2018.1430464] [Citation(s) in RCA: 88] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Current tissue regenerative strategies rely mainly on tissue repair by transplantation of the synthetic/natural implants. However, limitations of the existing strategies have increased the demand for tissue engineering approaches. Appropriate cell source, effective cell modification, and proper supportive matrices are three bases of tissue engineering. Selection of appropriate methods for cell stimulation, scaffold synthesis, and tissue transplantation play a definitive role in successful tissue engineering. Although the variety of the players are available, but proper combination and functional synergism determine the practical efficacy. Hence, in this review, a comprehensive view of tissue engineering and its different aspects are investigated.
Collapse
Affiliation(s)
- Behnaz Bakhshandeh
- a Department of Biotechnology, College of Science , University of Tehran , Tehran , Iran
| | - Payam Zarrintaj
- b School of Chemical Engineering, College of Engineering , University of Tehran , Tehran , Iran
| | - Mohammad Omid Oftadeh
- a Department of Biotechnology, College of Science , University of Tehran , Tehran , Iran.,c Stem Cell Technology Research Center , Tehran , Iran
| | - Farid Keramati
- a Department of Biotechnology, College of Science , University of Tehran , Tehran , Iran
| | - Hamideh Fouladiha
- a Department of Biotechnology, College of Science , University of Tehran , Tehran , Iran
| | - Salma Sohrabi-Jahromi
- d Gottingen Center for Molecular Biosciences , Georg August University , Göttingen , Germany
| | | |
Collapse
|